Skip to main content
TELO
NASDAQ Life Sciences

FDA Clears Telomir-Zn IND for Triple-Negative Breast Cancer, Paving Way for Phase 1/2 Trial

Tom Rudovsky · Reported by Access Newswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$1.489
Mkt Cap
$49.852M
52W Low
$1.05
52W High
$3.1
52W Position info
42% above low
Off High info
52% below high
Rel. Volume info
1.9× avg
Market data snapshot near publication time

TELO sits 42% above its 52-week low of $1.05 on elevated volume (1.9× avg).

Summary

Telomir Pharmaceuticals announced that the FDA has cleared its Investigational New Drug (IND) application for Telomir-Zn, its lead candidate for advanced or metastatic triple-negative breast cancer (TNBC). This critical regulatory milestone allows the company to initiate a first-in-human Phase 1/2 clinical trial in the first half of 2026, a significant step for a clinical-stage biotech. This positive development provides a crucial catalyst for the company, especially in light of its previously disclosed financial challenges and going concern warning from its last 10-K. While the company recently completed an acquisition to consolidate IP, this IND clearance directly advances its pipeline. Traders will now focus on the initiation of the Phase 1/2 trial and subsequent updates on patient enrollment and preliminary data.

At the time of this announcement, TELO was trading at $1.49 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $49.9M. The 52-week trading range was $1.05 to $3.10. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Access Newswire.


Price Chart

Share this article

Copied!

TELO - Latest Insights

TELO
Nov 06, 2026, 4:41 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.740
Real-time Price: $0.4208 info
Change: -$0.3192 (-43%) info
Market Cap: $31.003M info
TELO
Oct 27, 2026, 4:30 PM EDT
Filing Type: S-3
Importance Score:
7
Price at Filing: $1.02
Real-time Price: $0.4208 info
Change: -$0.5992 (-59%) info
Market Cap: $31.003M info
TELO
Oct 06, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.24
Real-time Price: $0.4208 info
Change: -$0.8192 (-66%) info
Market Cap: $31.003M info
TELO
Oct 06, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.28
Real-time Price: $0.4208 info
Change: -$0.8592 (-67%) info
Market Cap: $31.003M info
TELO
Aug 13, 2026, 5:10 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $1.05
Real-time Price: $0.4208 info
Change: -$0.6292 (-60%) info
Market Cap: $31.003M info